Architecture & Governance
Architecture & Governance
These documents define how the Population Standards Program is structured — how standards relate to one another, and the policy and governance frameworks that guide how they are developed, adopted, and maintained across clinical research and healthcare.
SGMA-ARC-001:
Population Standards Architecture Framework | Under Structured Commentary
SGMA-GOV-PP-001:
Population Policy Governance | Under Structured Commentary
SGMA-GOV-HIV-CV-001:
HIV Clinical Verification Governance | Under Structured Commentary
STANDARDS FAQs
Q: What are population standards?
Population standards are validated frameworks that define which populations are included in clinical research and healthcare — and how they are identified, characterized, and measured across systems. They provide the operational infrastructure to ensure population data is consistent, complete, and comparable.
Q: How are SGMA standards developed?:
Through a six-stage process: field gap identification, method development, expert review and consensus, standards publication, implementation guidance, and continuous update. All standards undergo structured commentary before publication.
Q: What does Under Structured Commentary mean?:
A formal review period where institutional stakeholders, advisors, and experts review drafts and provide feedback. Comparable to a public comment period in regulatory standards development. Documents may be revised based on feedback.
Q: How do I cite SGMA standards?:
Reference the document ID, full title, version, and publication date. For standards under commentary: [Document ID], [Title], SGMA, [Year], Under Structured Commentary. Formal citation guidelines published with each final standard.”
Q: What license are SGMA standards published under
Creative Commons Attribution 4.0 (CC BY 4.0) — free to download, adapt, share, and implement. Attribution to SGMA required.
Q: Are SGMA's standards about who gets included in trials, or how trial participants are characterized?
SGMA’s standards do not set representation requirements or enrollment quotas — that is regulatory territory. SGMA defines how populations are classified and operationalized across clinical research and healthcare: how they are identified across protocols and care settings, how they are consistently represented in studies, registries, and surveillance systems, and how that consistency is governed across global research and healthcare ecosystems. The goal is methodological consistency, not numerical targets.
Q: How are SGMA standards different from data standards?
Data standards define the format of clinical data — the structure of how information is recorded and exchanged. SGMA’s population standards address the classification and operational layer: how populations are defined and identified across protocols, eligibility logic, pharmacovigilance frameworks, and care delivery, and how that classification is governed consistently across global clinical research and healthcare systems. SGMA’s classification work is measure-agnostic — it can be applied to any validated SOGI instrument.
Q: What does it mean to implement a population standard?
Implementation means a sponsor, CRO, healthcare institution, or research network has integrated the standard into their operational infrastructure — protocol templates, eligibility criteria, case report forms, EMR phenotyping, safety monitoring, and analysis plans — in a way that produces consistent, auditable population data across studies, sites, and care settings.
Q: How do I participate in structured commentary?:
Contact standards@sgma.global. Open to sponsors, CROs, regulatory professionals, academic researchers, and healthcare institutions.
